| ALLIANZ HIGH DIVIDEND ASIA PACIFIC EQUITY I (H-EUR) EUR | RVI ASIA EX-JAPÓN VALOR | 58,17% | 88,17% | 54,27% | 95,28% |
| AB SICAV I-EMERGING MARKETS MULTI-ASSET PORTFOLIO A HKD | MIXTO FLEXIBLE | 34,13% | 69,13% | 41,62% | 95,27% |
| HSBC GIF ASIA EX JAPAN EQUITY SMALLER COMPANIES ID USD | RVI ASIA EX-JAPÓN SMALL/MID CAP | 25,43% | 48,20% | 22,23% | 95,25% |
| SEILERN INTERNATIONAL FUNDS PLC - SEILERN WORLD GROWTH CHF H R | RVI GLOBAL | -11,44% | -12,17% | -12,32% | 95,24% |
| AB SICAV I-EMERGING MARKETS MULTI-ASSET PORTFOLIO A USD | MIXTO FLEXIBLE | 34,14% | 69,11% | 41,56% | 95,22% |
| BNP PARIBAS EMERGING EQUITY CLASSIC CAP | RVI EMERGENTES | 59,08% | 87,99% | 42,65% | 95,20% |
| ALKEN FUND - ABSOLUTE RETURN EUROPE CH2 | RENT. ABSOLUTA. | 2,69% | 44,76% | 71,55% | 95,19% |
| M&G (LUX) GLOBAL EMERGING MARKETS FUND EUR C DIS | RVI EMERGENTES | 32,64% | 49,78% | 41,66% | 95,17% |
| ISHARES EMERGING MARKETS EQUITY INDEX FUND (LU) N7 USD DIS | RVI EMERGENTES | 41,78% | 62,08% | 28,61% | 95,16% |
| BGF WORLD HEALTHSCIENCE C2 USD | RVI BIOTECNOLOGÍA | 18,68% | 10,94% | 17,13% | 95,13% |
